Gsa Capital Partners LLP Cv Rx, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Cv Rx, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 263,682 shares of CVRX stock, worth $2.3 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
263,682
Previous 55,200
377.68%
Holding current value
$2.3 Million
Previous $675,000
129.63%
% of portfolio
0.11%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding CVRX
# of Institutions
94Shares Held
14.9MCall Options Held
42.2KPut Options Held
32.4K-
Johnson & Johnson New Brunswick, NJ4.1MShares$35.9 Million8.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$17.7 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.08MShares$9.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.65 Million0.0% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT789KShares$6.9 Million0.62% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $180M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...